Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial (vol 9, 54, 2023)Yang Yang,Yingjian He,Zhaoqing Fan,Xue Chen,Yiqiang Liu,Chao Zhang,Hongchuan Jiang,Xin Wang,Xiang Wang,Fei Xie,Shu Wang,Bin Luo,Hua Kang,Tao Wang,Zefei Jiang,Peng Yuan, Binhe Xu,Ling Xu,Yinhua Liu,Jinfeng Li,Yuntao Xie,Tianfeng Wang,Tao OuyangNPJ BREAST CANCER（2023）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
